Animal Model Market Analysis, Size, Growth & Forecast [2030]
Animal Model Market Analysis, Size, Growth & Forecast [2030]
Segments - Animal Model Market by Animal Types (Rabbits, Guinea Pigs, Mice, Rat, Dog, and Others), Applications (Basic Research, Drug Discovery & Development, and Others), End-users (Academic Research Institutes, Pharma & Biotech Companies, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
Upcoming
| Report ID :HC-4632
| 4.3 Rating
| 62 Reviews
| 198 Pages
| Format :
Report Description
The animal model market size was valued at USD 1468 million in 2021 and is projected to reach USD 2678 million by 2030, expanding at a CAGR of around 6% during the forecast period, 2022 – 2030. The growth of the market is attributed to the software modeling for time and cost savings, as well as the increased awareness of ethical issues with minimizing the use of live animals in research.
A non-human species called an animal model is one that is employed in biomedical research as it can replicate some characteristics of a disease or biological process that affects people. The anatomy, physiology, and responses of animal models to pathogens are substantially similar to those of people that researchers can interpret the findings of animal model studies to better comprehend human physiology and disease. Researchers can conduct studies that would be impractical or unethical to conduct on humans using animal models. Natural occurrences of a certain disease in the animal being researched are known as spontaneous animal models. Dogs, for example, are the only naturally occurring animal model for prostate cancer, a serious condition that affects human health. In investigations of almost every human condition, animal models have generally been useful.
The covid-19 pandemic has impacted almost every industry in the world. The animal model market is positively impacted during the covid-19. In order to stop coronavirus infections, there is a growing need for COVID-19 diagnosis, prevention, and treatment solutions. In order to stop infections caused by coronavirus, there is significant demand for COVID-19 detection, prevention, and treatment solutions. For the development of antiviral drugs and vaccines against COVID-19, the use of animal models is expanding significantly.
Market Trends, Drivers, Restraints, and Opportunities
- Growing demand for specialized medications and increased use of genetics in biomedical research is projected to drive the market.
- Increased use of animal models in pre-clinical development by several research facilities and the biopharmaceutical industry is anticipated to fuel the market during the forecast period.
- Rising government funding for new ideas and the development of guidelines related to animal models is expected to boost the market.
- The ethical use of animals in research is governed by rules and regulations, which is anticipated to hinder the market growth.
- R&D investment and technological advancement in animal model is estimated to create immense opportunities for the market players.
Scope of the Report
The report on the global animal model market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Animal Model Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2019–2020 |
|
Forecast Period |
2022 – 2030 |
|
Segmentation |
Animal Types (Rabbits, Guinea Pigs, Mice, Rat, Dog, and Others), Applications (Basic Research, Drug Discovery & Development, and Others), End-users (Academic Research Institutes, Pharma & Biotech Companies, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
The Jackson Laboratory; Taconic Biosciences; PerkinElmer, Inc. (Horizon Discovery Group plc.); Ozgene Pty Ltd.; JSR Corporation (Crown Bioscience Inc.); Hera BioLabs (Transposagen Biopharmaceuticals); GenOway S.A.; Eurofins Scientific SE; Envigo; and Charles River Laboratories International, Inc. |
Market Segment Insights
The rat segment is estimated to dominate the market during the forecast period
Based on animal types, the market is segregated into rabbits, guinea pigs, mice, rat, dog, and others. The rat segment accounted for a major market share in 2021 and is projected to maintain its dominance during the forecast period owing to increasing use of rat models to research several complicated illnesses. Increased use of personalized medicine in emerging and developed nations, improvements in gene editing tools, and rising use of rat models in drug research and development are the major factors boosting the segment.
The drug discovery & development segment is projected to grow at a rapid pace
On the basis of applications, the market is fragmented into basic research, drug discovery & development, and others. The drug discovery & development accounted for a major market share in 2021 due to increasing preclinical activities, drug testing, and the use of animal models in drug discovery and development, as well as the manufacturing of novel products by pharmaceutical and biotechnology businesses. Moreover, increased research and development (R&D) operations in the pharmaceutical and biotech industries, which require animal testing to ensure the safety and efficacy of products is driving the segment.
The pharma & biotech companies segment held a key market share in 2021
In terms of end-users, the market is divided into academic research institutes, pharma & biotech companies, and others. The pharma & biotech companies segment held a key market share in 2021 owing to the development of new technology, introduction of less expensive and more effective research methodologies, and rising investment. Continuous advancements in the field of customized medicine have provided a lot of opportunities to cure various diseases. This is anticipated to stimulate the use of animal-based models in research on precision medicine.
Asia Pacific is anticipated to dominate the market in the coming years
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to dominate the market in the coming years due to increasing government initiatives and funding for overall drug research and development utilizing animal models, as well as growing significance of mouse clinical trials (MCTs) for more accurate result projection. The market for animal models in the region is anticipated to increase as a result of top manufacturers putting a greater emphasis on regional expansion into rising Asia-Pacific nations in order to gain a large proportion of the industry.
Segments
The global animal model market has been segmented on the basis of
Animal Types- Rabbits
- Guinea Pigs
- Mice
- Rat
- Dog
- Others
- Basic Research
- Drug Discovery & Development
- Others
- Academic Research Institutes
- Pharma & Biotech Companies
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- The Jackson Laboratory
- Taconic Biosciences
- PerkinElmer, Inc. (Horizon Discovery Group plc.)
- Ozgene Pty Ltd.
- JSR Corporation (Crown Bioscience Inc.)
- Hera BioLabs (Transposagen Biopharmaceuticals)
- GenOway S.A.
- Eurofins Scientific SE
- Envigo
- Charles River Laboratories International, Inc.
Competitive Landscape
Key players competing in the animal model market include The Jackson Laboratory; Taconic Biosciences; PerkinElmer, Inc. (Horizon Discovery Group plc.); Ozgene Pty Ltd.; JSR Corporation (Crown Bioscience Inc.); Hera BioLabs (Transposagen Biopharmaceuticals); GenOway S.A.; Eurofins Scientific SE; Envigo; and Charles River Laboratories International, Inc. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares. For instance,
- In January 2020, Horizon Discovery Group confirmed cooperation and license agreement with Mammoth Biosciences in order to use Mammoth's distinctive CRISPR technology.
- In September 2021, Envigo was acquired by Inotiv Inc. with this acquisition, both companies will have easy access to goods and services for all phases of non-clinical research and development under a single organization.
Frequently Asked Questions
The Jackson Laboratory; Taconic Biosciences; PerkinElmer, Inc. (Horizon Discovery Group plc.); and Ozgene Pty Ltd. are the leading players in the animal model market.
Academic research institutes, pharma & biotech companies, and others are the end-users in the animal model market.
The animal model market is anticipated to expand at a CAGR of around 6% during the forecast period, 2022 – 2030.
The animal model market is projected to reach USD 2678 million by 2030.
The animal model market size was valued at USD 1468 million in 2021.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Animal Model Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Animal Model Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Animal Model Market - Supply Chain
4.5. Global Animal Model Market Forecast
4.5.1. Animal Model Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Animal Model Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Animal Model Market Absolute $ Opportunity
5. Global Animal Model Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Animal Model Market Size and Volume Forecast by Applications
5.3.1. Basic Research
5.3.2. Drug Discovery & Development
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Animal Model Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Animal Model Market Size and Volume Forecast by End Users
6.3.1. Academic Research Institutes
6.3.2. Pharma & Biotech Companies
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Animal Model Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Animal Model Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Animal Model Demand Share Forecast, 2019-2026
8. North America Animal Model Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Animal Model Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Animal Model Market Size and Volume Forecast by Applications
8.4.1. Basic Research
8.4.2. Drug Discovery & Development
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Animal Model Market Size and Volume Forecast by End Users
8.7.1. Academic Research Institutes
8.7.2. Pharma & Biotech Companies
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Animal Model Demand Share Forecast, 2019-2026
9. Latin America Animal Model Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Animal Model Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Animal Model Market Size and Volume Forecast by Applications
9.4.1. Basic Research
9.4.2. Drug Discovery & Development
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Animal Model Market Size and Volume Forecast by End Users
9.7.1. Academic Research Institutes
9.7.2. Pharma & Biotech Companies
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Animal Model Demand Share Forecast, 2019-2026
10. Europe Animal Model Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Animal Model Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Animal Model Market Size and Volume Forecast by Applications
10.4.1. Basic Research
10.4.2. Drug Discovery & Development
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Animal Model Market Size and Volume Forecast by End Users
10.7.1. Academic Research Institutes
10.7.2. Pharma & Biotech Companies
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Animal Model Demand Share Forecast, 2019-2026
11. Asia Pacific Animal Model Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Animal Model Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Animal Model Market Size and Volume Forecast by Applications
11.4.1. Basic Research
11.4.2. Drug Discovery & Development
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Animal Model Market Size and Volume Forecast by End Users
11.7.1. Academic Research Institutes
11.7.2. Pharma & Biotech Companies
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Animal Model Demand Share Forecast, 2019-2026
12. Middle East & Africa Animal Model Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Animal Model Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Animal Model Market Size and Volume Forecast by Applications
12.4.1. Basic Research
12.4.2. Drug Discovery & Development
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Animal Model Market Size and Volume Forecast by End Users
12.7.1. Academic Research Institutes
12.7.2. Pharma & Biotech Companies
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Animal Model Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Animal Model Market: Market Share Analysis
13.2. Animal Model Distributors and Customers
13.3. Animal Model Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. The Jackson Laboratory
13.4.2. Taconic Biosciences
13.4.3. PerkinElmer, Inc. (Horizon Discovery Group plc.)
13.4.4. Ozgene Pty Ltd.
13.4.5. JSR Corporation (Crown Bioscience Inc.)
13.4.6. Hera BioLabs (Transposagen Biopharmaceuticals)
13.4.7. GenOway S.A.
Methodology
Related Reports
Some other reports from this category!
Our Clients
